At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. We focus on creating new therapies in the areas of pain management, oncology, ophthalmology and infectious diseases.
Effective drug development is a challenging and complex effort that requires the coordinated talents of many skilled individuals working as a team.
If you believe in the potential for new medicines to improve quality of life and bring hope to those in need, we invite you to join us. We welcome applications from all over the globe.
Company Details
- Employees
- 27
- Founded
- -
- Address
- 2f, 3 Yuanqu Street, Nangang District,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- tlcbio.com
- Keywords
- Nanomedicine, Drug Delivery, Drug Discovery, Drug Development, Oncology, Ophthalmology, Pain Management, Osteoarthritis.
- HQ
- Taipei
Tlc Biosciences Questions
Tlc Biosciences's website is tlcbio.com
Tlc Biosciences's LinkedIn profile is https://www.linkedin.com/company/tlcbio
Tlc Biosciences has
27 employees.
View email and phone details for 27
employees at Tlc Biosciences.
Tlc Biosciences's industry is
Biotechnology Research
Tlc Biosciences's top competitors are
Dialectic Therapeutics Inc,
Qps Holdings, Llc,
Twi Pharmaceuticals, Inc.,
Inventiv Health Clinical,
Formosa Laboratories, Inc.,
Foresee Pharmaceuticals,
Lumosa Therapeutics Co., Ltd.,
Novo Nordisk,
Lin Bioscience,
Obi Pharma.
Tlc Biosciences's categories are Biotechnology Research
Tlc Biosciences's founding year is 1997
